1,3-butylene Glycol

1,3-butylene glycol (CAS Number 107-88-0) is a four-carbon diol, a type of organic compound containing two hydroxyl groups. It is a clear, viscous liquid with hygroscopic properties, meaning it readily absorbs moisture from the environment. The compound is synthetic and does not occur naturally in significant quantities. Chemically, it is distinct from propylene glycol, another commonly used food additive, though both serve similar functional purposes in food manufacturing.

In the food industry, 1,3-butylene glycol functions primarily as a solvent and vehicle for flavoring agents. Its ability to dissolve both water-soluble and fat-soluble flavor compounds makes it valuable in beverage formulations, particularly in flavored drinks, soft drinks, and concentrated flavor systems. The additive is also used in confectionery products, baked goods, and dairy applications where flavor distribution and stability are important considerations.

Beyond food, 1,3-butylene glycol appears in cosmetics, pharmaceuticals, and personal care products for similar solvent and humectant properties. In these non-food applications, it is more widely established than in food manufacturing.

According to FDA records, there have been zero adverse events and zero recalls associated with 1,3-butylene glycol in food products. This safety record reflects minimal reported consumer harm in the United States food supply.

Notably, 1,3-butylene glycol has not received GRAS (Generally Recognized as Safe) status from the FDA, which distinguishes it from additives like propylene glycol that carry this designation. GRAS status indicates that an ingredient is generally recognized as safe based on scientific procedures or common use in food prior to 1958. The absence of GRAS status does not automatically indicate a safety concern; rather, it reflects that this particular additive has not undergone the formal GRAS review process with the FDA or does not meet the historical use criteria.

Limited published toxicological data exists specifically for 1,3-butylene glycol in the food safety literature. Animal studies conducted on similar glycols suggest low acute toxicity when ingested, though formal comprehensive safety assessments for this specific compound in food applications have not been as extensively documented as for more commonly used food additives.

In the United States, 1,3-butylene glycol's regulatory status remains ambiguous. Without GRAS status and without explicit FDA approval as a food additive, its legal use in food is questionable under current regulations. Manufacturers using this ingredient should verify compliance with FDA regulations and may need to establish its safety through a food additive petition if regulatory clarity is required.

Regulatory approaches differ internationally. The European Food Safety Authority (EFSA) and other regulatory bodies may classify this ingredient differently. Food manufacturers must ensure compliance with regulations in all markets where their products are sold.

Direct peer-reviewed research on 1,3-butylene glycol as a food additive is sparse in the published literature. Available toxicological data comes primarily from non-food applications and occupational exposure studies. General glycol toxicology indicates that these compounds are metabolized by the liver and excreted through urine, with the kidneys being a target organ at high doses in animal models.

Comparative studies with propylene glycol, a structurally similar and more established food additive, suggest similar metabolic pathways, though direct equivalency cannot be assumed. The absence of documented adverse events in food use, combined with limited safety data, means the risk profile remains incompletely characterized for food applications specifically.